# Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT

> **NCT02349178** · PHASE2 · TERMINATED · sponsor: **Medical College of Wisconsin** · enrollment: 6 (actual)

## Conditions studied

- Leukemia, Acute Lymphoblastic
- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Clofarabine
- **DRUG:** Cyclophosphamide
- **DRUG:** Etoposide

## Key facts

- **NCT ID:** NCT02349178
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12-08
- **Primary completion:** 2017-03-16
- **Final completion:** 2017-03-16
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2020-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02349178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02349178, "Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02349178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*